Bio Techne | TECH - 营业利润



金融业
股票价格
USD
资产
USD 2.55B
现金及等价物
USD 264.71M
销售成本
USD 103.13M
流动资产
USD 688.05M
流动负债
USD 153.28M
债务
USD 200M
股息收益率
0.61
EBIT
USD 75.5M
EBITDA
USD 115.94M
员工
3.1K
EPS每股收益
USD 0.52
股本和储备
USD 2.09B
销售毛利
USD 222.15M
债务利息支出
USD 3.6M
利息收入
USD 981K
贷款资金
USD 200M
市值
USD 11.37B
净收入
USD 51.05M
营业费用
USD 235.92M
营业利润
USD 75.5M
普通股股本
USD 156.45M
PE价格收益
38.75
税前利润
USD 106.09M
销售收入
USD 321.2M
销售和管理费用
USD 109.34M
股票
USD 195.74M
贸易债权人
USD 95.6M
应收帐款人
USD 214.56M


营业利润 更改 日
Agilent USD 399M 46M 2026-03
Becton, Dickinson and Co. USD 752M 125M 2026-06
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 72.6M 38.5M 2026-06
Bruker USD 69.6M 59.4M 2026-06
Charles River Laboratories USD 119.89M 9K 2026-06
Danaher USD 1.13B 217M 2026-06
Illumina USD 260M 21M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Merck EUR 1.1B 51M 2026-06
Mettler Toledo International USD 287.55M 53.61M 2026-06
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Repligen USD 21.13M 1.15M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Standard Biotools USD -9.42M 12.51M 2026-03
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Waters USD -86M 234M 2026-06